Sublocade versus Probuphine, which one is better?
Sublocade and Probuphine are two of the newest medical treatments for opiate and opioid dependence. In fact, they could possibly become the new standard, replacing the existing sublingual tablets and films. Sublocade is a monthly injection. Probuphine is a twice yearly implant. So, Sublocade versus Probuphine, which is better?
The benefits of Sublocade treatment.
If you are tired of the daily wait for your Suboxone or Subutex to dissolve under your tongue, the monthly shot may be for you. All you will have to do is go to your monthly doctor visit. Your shot will be shipped to the doctor and he or she will give it to you in the office. That’s it. Finally, you can skip the pharmacy and just go home or to work.
The benefits of Probuphine.
While the probuphine implant requires a minor surgical procedure, you only need to do it once every six months. While doctor visits and therapy sessions are still important, you now have more flexibility. So, if you travel the world for extended time periods, the implant may be ideal for you.
Is Sublocade better?
I personally see Sublocade as being the preferred choice for more patients. First of all, it does not require surgery. Probuphine surgery has risks. These risks include nerve damage and infection. Sublocade is a simple shot that goes just under the skin. However, it doesn’t make it better for everyone.
Probuphine may be better later in treatment.
While Sublocade can be used for patients on anywhere from 8mg to 24mg of daily suboxone, Probuphine is for patients who are stable on 8mg or less of daily Suboxone. Sublocade is intended for early treatment. Probuphine may be more ideal for patients who have been on medical treatment for at least a year. It could be used for a very gradual tapering schedule over a period of one to two years.
Will Suboxone, Subutex and ZubSolv be discontinued?
It is my opinion that there will always be a place for the traditional, under-the-tongue medications. Therefore, I believe that these traditional therapies will always be available. However, we may see a transition to most patients being treated with either Sublocade or Probuphine. In fact, the question of Sublocade versus Probuphine may not be an issue in years to come. We can expect even newer and better therapies to be developed and released in the future.